Big pharma vs biotech and the future of marketing

Meet GOLD's recent catalyst – Claus Zieler

Medical affairs evolution and the future for MSLs

Men's Health Week special

Killing projects, drug discovery and career progression

Gamification: retaining a human touch and enhancing culture

Pharma in South Africa, access, pricing and reimbursement

Learnings from the Next Pharma Summit

Communication, data in R&D and leadership

Mental health: awareness, access and influence in pharma

Social sustainability, patient advocacy and policy campaigning

RWE, the metrics of medical affairs and TikTok marketing

Driving access to digital, gene therapies and rare disease education

2022 pharma predictions – where are we now?

Meet GOLD's next catalyst - digital innovator, Davidek Herron

Innovation, collaboration and creativity as a contact sport

Pharma in China, untapped markets and drug development

Claire Skentelbery, Director General, EuropaBio

The risks, rewards and future potential of biotechnology

GP insights, preventative care and patient centricity